>>Signaling Pathways>> GPCR/G protein>> Leukotriene Receptor>>(S)-Verapamil D7 hydrochloride

(S)-Verapamil D7 hydrochloride (Synonyms: (S)-(-)-Verapamil D7 hydrochloride)

Catalog No.GC60425

(S)-Verapamil D7 염산염((S)-(-)-Verapamil D7 염산염)은 (S)-Verapamil 염산염으로 표지된 중수소입니다. (S)-Verapamil 염산염(S(-)-Verapamil 염산염)은 MRP1에 의한 류코트리엔 C4(LTC4)와 칼세인 수송을 억제합니다. (S)-Verapamil 염산염은 잠재적으로 내성이 있는 종양 세포를 죽입니다.

Products are for research use only. Not for human use. We do not sell to patients.

(S)-Verapamil D7 hydrochloride Chemical Structure

Size 가격 재고 수량
1mg
US$213.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(S)-Verapamil D7 hydrochloride ((S)-(-)-Verapamil D7 hydrochloride) is a deuterium labeled (S)-Verapamil hydrochloride. (S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) inhibits leukotriene C4 (LTC4) and calcein transport by MRP1. (S)-Verapamil hydrochloride leads to the death of potentially resistant tumor cells[1][2].

[1]. Perrotton T, et al. (R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1. J Biol Chem. 2007 Oct 26;282(43):31542-8. Epub 2007 Jul 22. [2]. Tannergren C, et al. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther. 2004 Apr;75(4):298-309.

리뷰

Review for (S)-Verapamil D7 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (S)-Verapamil D7 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.